Replies to post #380661 on Elite Pharmaceuticals Inc (ELTP)

[JamesF1]

Bloomberg recently reported “Purdue Patents for Extended-Release OxyContin Nixed in Intas Win” I think a link was posted on this thread a couple of weeks ago.

[The ELTP King]

2023

Purdue has been able to file new patents for OxyContin 13 times with the US Patent and Trademark Office over the past decade, thereby extending its exclusive selling rights on the drug through 2030.

[mrwrn2010]

Lol such a joke.

[NASDAQ2020]

No more Purdue lost ALL of that in Court recently

Not good for Purdue -- Great for ELITE

HammerTime !!!!!!!!!!!!!!